EE51 A Cost-Consequence Analysis of Adopting Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma in Saudi Arabia: a Multi-Center Comparison
Abstract
Authors
H.A. Al-Abdulkarim A. Alrajhi M. Alzahrani S. Alamoudi M. Khan G. Ball M. Alharbi W. Mereani